| View |
|
DRP-8028-01
|
Neomycin sulfate + Polymyxin B sulfate + Fluocinolone acetonide
|
Triclir
|
3.5 mg/ 10,000 Units / 250 mcg per mL
|
Otic Solution
|
Topical Antibiotic/ Corticosteroid
|
Pascual Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
24 June 2024
|
14 July 2026
|
| View |
|
DRP-8138-04
|
Tobramycin
|
Tobiclear
|
3 mg / mL (0.3% w/v)
|
Ophthalmic Solution (Drops)
|
Anti-infectives
|
Daewoo Pharm. Co., Ltd
|
Korea
|
Renewal
|
16 August 2024
|
31 October 2029
|
| View |
|
DRP-8339-06
|
Telmisartan
|
Telmicass
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
23 June 2024
|
07 May 2029
|
| View |
|
DRP-8396-08
|
Omeprazole (as Sodium)
|
Omeprob
|
40 mg
|
Powder for Injection (IV)
|
Proton Pump Inhibitor
|
CSPC Ouyi Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
30 June 2024
|
19 November 2028
|
| View |
|
DRP-8452-01
|
Paracetamol
|
None
|
120 mg/5 mL
|
Oral Suspension
|
Analgesic/Antipyretic
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
19 June 2024
|
14 May 2025
|
| View |
|
DRP-8492-01
|
Hyoscine-N-Butylbromide
|
None
|
10 mg
|
Tablet
|
Anticholinergic
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
19 June 2024
|
27 March 2027
|
| View |
|
DRP-8522-06
|
Losartan Potassium
|
JIAAZAR
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
13 October 2024
|
25 October 2029
|
| View |
|
DRP-8590-01
|
Donepezil hydrochloride
|
Dosena-10
|
10 mg
|
Orodispersible Tablet
|
Cholinesterase Inhibitor
|
Nobel llac Sanayii Ticaret A.S.
|
Turkey
|
Initial
|
12 March 2021
|
18 December 2024
|
| View |
|
DRP-864-06
|
Polymyxin B Sulfate + Neomycin Sulfate + Dexamethasone (as Sodium Phosphate)
|
PND-Care
|
10,000 units/5 mg/1 mg per mL
|
Otic Solution
|
Antibacterial / Corticosteroid
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
30 June 2024
|
31 January 2028
|
| View |
|
DRP-8717-02
|
Carvedilol
|
None
|
25 mg
|
Film-Coated Tablet
|
Combined Alpha and Beta-Adrenoceptor Blocker
|
Medley Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
19 June 2024
|
26 April 2027
|
| View |
|
DRP-8736-02
|
Ketorolac Trometamol
|
Flamlife
|
30 mg/mL
|
Solution for Injection (I.M./I.V.)
|
Non-Steroidal Anti-inflammatory Drug (NSAID)
|
Farbe Firma Pvt. Ltd
|
India
|
CLIDP Conversion
|
18 June 2024
|
17 April 2025
|
| View |
|
DRP-887-16
|
Thiamine Mononitrate (Vit. B1) + Pyridoxine Hydrochloride (Vit. B6) + Cyanocobalamin (Vit. B12)
|
Neuronav Forte
|
300mg/ 100mg/ 100 mcg
|
Capsule
|
Vitamin
|
J.M. Tolmann Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
19 June 2024
|
22 August 2026
|
| View |
|
DRP-8933-02
|
Buclizine HCl + Multivitamin + Iron
|
Apetab
|
(See reverse for formulation)
|
Capsule
|
Vitamins + Minerals
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
24 June 2024
|
01 July 2025
|
| View |
|
DRP-9024-01
|
Cetirizine dihydrochloride
|
Erilife
|
10 mg
|
Film-Coated Tablet
|
Antihistamine
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
18 June 2024
|
04 August 2025
|
| View |
|
DRP-9183-03
|
Lactulose
|
Laxipate
|
3.33 g / 5 mL
|
Syrup
|
Laxative
|
Stallion Laboratories Pvt. Ltd.
|
|
CLIDP Conversion
|
24 June 2024
|
30 September 2025
|
| View |
|
DRP-9417-02
|
Trimetazidine dihydrochloride
|
Metalife
|
35 mg
|
Modified Release Tablet
|
Antianginal Agent (Fatty Acid Oxidation (pFOX) Inhibitor)
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
18 June 2024
|
23 December 2025
|
| View |
|
DRP-9447-01
|
Salbutamol (as sulfate)
|
Brevalife
|
100 mcg/dose (200 doses per container)
|
Metered Dose Inhaler
|
Bronchodilator (Selective Beta-2-Adrenoreceptor Agonist)
|
Heilongjiang Province Fulckang Pharmaceutical Co., Ltd
|
China
|
Renewal
|
23 August 2024
|
06 September 2029
|
| View |
|
DRP-9544-03
|
Ascorbic Acid + Zinc + Cholecalciferol (Vitamin D3)
|
None
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate)/ 10 mg (equivalent to 70 mg Zinc Gluconate)/1,000 IU
|
Capsule
|
Vitamins/Mineral
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
19 June 2024
|
17 February 2026
|
| View |
|
DRP-9583-01
|
Atorvastatin (as calcium)
|
None
|
40 mg
|
Film Coated Tablet
|
Antihyperlipidemia (HMG-CoA Reductase Inhibitor)
|
Micro Labs Limited
|
India
|
CLIDP Conversion
|
23 June 2024
|
23 October 2028
|
| View |
|
DRP-9872-03
|
Iron + Riboflavin (Vitamin B2) + Cyanocobalamin (Vitamin B12) + Folic Acid
|
Ferronav
|
165 mg/2 mg/3mcg/ 230 mcg
|
Capsule
|
Anti-Anemic
|
J.M. Tolmann Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
24 June 2024
|
13 December 2026
|